Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Multiplex PCR Assays Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The market size for multiplex pcr assays has undergone significant expansion in recent years. It is projected to grow from $1.7 billion in 2025 to $1.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.4%. The historical increase can be linked to factors such as the escalating burden of infectious diseases, the broader adoption of molecular diagnostics, limitations inherent in singleplex pcr testing, a rising need for rapid diagnostic results, and the development of diagnostic laboratory infrastructure.
The multiplex PCR assays market is anticipated to undergo significant expansion in the coming years. It is projected to reach $3.17 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 13.2%. This growth throughout the forecast period is driven by an increased focus on early disease detection, a growing need for comprehensive diagnostic solutions, the expansion of personalized medicine approaches, rising investments in molecular diagnostics, and the increasing adoption of multiplex assays in routine testing. Prominent trends expected during this period include the rising acceptance of multiplex testing for infectious diseases, an escalating demand for high-throughput diagnostic assays, the expanding use of syndromic testing panels, the broader application of multiplex PCR in clinical diagnostics, and a growing preference for cost-effective multi-target assays.
Get A Free Sample Report With In-Depth Market Insights:
Multiplex PCR Assays Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The growing need for diagnostic testing is projected to fuel the expansion of the multiplex PCR assay market in the future. Diagnostic testing encompasses methods or examinations employed to ascertain the presence or absence of illnesses or conditions in individuals. This escalating requirement for diagnostic testing stems from the rise in chronic illnesses such as cancer and diabetes, necessitating prompt and precise diagnosis for successful management. Furthermore, an emphasis on preventive healthcare promotes routine screening to identify potential problems early. Multiplex PCR assays facilitate the simultaneous identification and examination of multiple pathogens or genetic indicators from one sample, thereby boosting the effectiveness and thoroughness of diagnostic testing. For instance, in July 2024, data from the National Health Service (NHS), a U.K.-based hospital and healthcare provider, revealed that diagnostic activity surpassed pre-pandemic levels in 2023. This included a 21% increase in tests conducted in May 2024 compared to 2023, with a total of 2.4 million diagnostic tests performed in May 2024. Consequently, the heightened demand for diagnostic testing is set to drive the growth of the multiplex PCR assay market.
Multiplex PCR Assays Market Segmentation: How Does The Market Break Down By Category?
The multiplex pcr assays market covered in this report is segmented –
1) By Assay Type: Planar Assay, Bead Based Assay
2) By Product And Services: Consumables, Instruments, Software And Services
3) By Application: Disease Diagnosis, Research And Development, Other Applications
4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users
Subsegments:
1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays
2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays
Multiplex PCR Assays Market Innovation Trends Shaping Future Development
Leading companies within the multiplex PCR assays market are concentrating on embedding automation, including next-generation quantitative PCR (qPCR) systems, to ensure accurate and versatile nucleic acid quantification for advanced clinical diagnostics and public health applications. These cutting-edge qPCR systems facilitate high-throughput, precise, and simultaneous identification of multiple targets, thereby boosting diagnostic accuracy and operational efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a diagnostic system solutions producer based in Switzerland, introduced the LightCycler PRO System. This advanced qPCR platform offers rapid, accurate, and concurrent detection of various targets. It incorporates superior temperature uniformity, sophisticated software, and supports over 200 LightMix Modular and 60 CE-IVD assays, leading to improved diagnostic accuracy and efficiency. This system serves as a prime illustration of automation’s integration into the multiplex PCR assays market, fostering progress in clinical diagnostics and public health.
Multiplex PCR Assays Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc, Agena Bioscience, Fluidigm Corporation
View The Full Multiplex PCR Assays Market Report:
Multiplex PCR Assays Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the multiplex PCR assays market in 2025. The regions covered in the multiplex pcr assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
